Mega-analysis of association between obesity and cortical morphology in bipolar disorders: ENIGMA study in 2832 participants

BACKGROUND Obesity is highly prevalent and disabling, especially in individuals with severe mental illness including bipolar disorders (BD). The brain is a target organ for both obesity and BD. Yet, we do not understand how cortical brain alterations in BD and obesity interact. METHODS We obtained body mass index (BMI) and MRI-derived regional cortical thickness, surface area from 1231 BD and 1601 control individuals from 13 countries within the ENIGMA-BD Working Group. We jointly modeled the statistical effects of BD and BMI on brain structure using mixed effects and tested for interaction and mediation. We also investigated the impact of medications on the BMI-related associations. RESULTS BMI and BD additively impacted the structure of many of the same brain regions. Both BMI and BD were negatively associated with cortical thickness, but not surface area. In most regions the number of jointly used psychiatric medication classes remained associated with lower cortical thickness when controlling for BMI. In a single region, fusiform gyrus, about a third of the negative association between number of jointly used psychiatric medications and cortical thickness was mediated by association between the number of medications and higher BMI. CONCLUSIONS We confirmed consistent associations between higher BMI and lower cortical thickness, but not surface area, across the cerebral mantle, in regions which were also associated with BD. Higher BMI in people with BD indicated more pronounced brain alterations. BMI is important for understanding the neuroanatomical changes in BD and the effects of psychiatric medications on the brain.

[1]  Sean R. McWhinney,et al.  Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals , 2022, Molecular Psychiatry.

[2]  Erick Jorge Canales-Rodríguez,et al.  Diagnosis of bipolar disorders and body mass index predict clustering based on similarities in cortical thickness—ENIGMA study in 2436 individuals , 2021, Bipolar disorders.

[3]  K. Koly,et al.  Prevalence of Overweight and Obesity in People With Severe Mental Illness: Systematic Review and Meta-Analysis , 2021, Frontiers in Endocrinology.

[4]  R. Simó,et al.  Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants , 2021, Neuroscience & Biobehavioral Reviews.

[5]  N. García-Casares,et al.  Obesity and Gray Matter Volume Assessed by Neuroimaging: A Systematic Review , 2021, Brain sciences.

[6]  Sean R. McWhinney,et al.  Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis-A Longitudinal Study. , 2021, Schizophrenia bulletin.

[7]  Janice M. Fullerton,et al.  Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals , 2021, Molecular Psychiatry.

[8]  Erick Jorge Canales-Rodríguez,et al.  What we learn about bipolar disorder from large‐scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group , 2020, Human brain mapping.

[9]  Dan J Stein,et al.  Brain structural abnormalities in obesity: relation to age, genetic risk, and common psychiatric disorders , 2020, Molecular Psychiatry.

[10]  A. Fagiolini,et al.  Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders , 2020, Bipolar disorders.

[11]  M. Kolenič,et al.  Insulin resistance is associated with verbal memory impairment in bipolar disorders. , 2020, Journal of affective disorders.

[12]  Rebecca C. Knickmeyer,et al.  ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries , 2019, Biological Psychiatry.

[13]  M. Alda,et al.  Brain age in bipolar disorders: Effects of lithium treatment , 2019, The Australian and New Zealand journal of psychiatry.

[14]  Philip R Jansen,et al.  Obesity, Brain Volume, and White Matter Microstructure at MRI: A Cross-sectional UK Biobank Study. , 2019, Radiology.

[15]  B. Shan,et al.  Gray matter reduction related to decreased serum creatinine and increased triglyceride, Hemoglobin A1C, and low-density lipoprotein in subjects with obesity , 2019, Neuroradiology.

[16]  Mark E Bastin,et al.  Associations between vascular risk factors and brain MRI indices in UK Biobank , 2019, bioRxiv.

[17]  W. Honer,et al.  Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study , 2018, Bipolar disorders.

[18]  Adrian Preda,et al.  Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium , 2018, Biological Psychiatry.

[19]  Erick Jorge Canales-Rodríguez,et al.  Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group , 2018, Molecular Psychiatry.

[20]  Alan C. Evans,et al.  Neuroanatomical differences in obesity: meta-analytic findings and their validation in an independent dataset , 2018, International Journal of Obesity.

[21]  R. McIntyre,et al.  Obesity and frontal‐striatal brain structures in offspring of individuals with bipolar disorder: Results from the global mood and brain science initiative , 2018, Bipolar disorders.

[22]  Eric J. Brunner,et al.  Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study , 2018, Alzheimer's & Dementia.

[23]  Erick Jorge Canales-Rodríguez,et al.  Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group , 2017, Molecular Psychiatry.

[24]  B. MacIntosh,et al.  Greater body mass index is associated with reduced frontal cortical volumes among adolescents with bipolar disorder. , 2018, Journal of psychiatry & neuroscience : JPN.

[25]  R. McIntyre,et al.  Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders , 2017, European Neuropsychopharmacology.

[26]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[27]  I. Melle,et al.  Brain volume change in first‐episode psychosis: an effect of antipsychotic medication independent of BMI change , 2017, Acta psychiatrica Scandinavica.

[28]  V. Arolt,et al.  Prefrontal gray matter volume mediates genetic risks for obesity , 2017, Molecular Psychiatry.

[29]  Riitta Parkkola,et al.  Bariatric Surgery Induces White and Grey Matter Density Recovery in the Morbidly Obese: A Voxel‐Based Morphometric Study , 2016, Human brain mapping.

[30]  S. Woods,et al.  Antipsychotic‐induced weight gain in first‐episode psychosis patients: a meta‐analysis of differential effects of antipsychotic medications , 2016, Early intervention in psychiatry.

[31]  Palaniyandi Ravanan,et al.  Secret talk between adipose tissue and central nervous system via secreted factors—an emerging frontier in the neurodegenerative research , 2016, Journal of Neuroinflammation.

[32]  O. Andreassen,et al.  Subcortical volumetric abnormalities in bipolar disorder , 2016, Molecular Psychiatry.

[33]  N. Beckett,et al.  The risk of overweight/obesity in mid-life and late life for the development of dementia: a systematic review and meta-analysis of longitudinal studies. , 2016, Age and ageing.

[34]  Mohamad Habes,et al.  Association between waist circumference and gray matter volume in 2344 individuals from two adult community-based samples , 2015, NeuroImage.

[35]  D. Vancampfort,et al.  Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis , 2015, World psychiatry : official journal of the World Psychiatric Association.

[36]  A. Villringer,et al.  Physical exercise in overweight to obese individuals induces metabolic- and neurotrophic-related structural brain plasticity , 2015, Front. Hum. Neurosci..

[37]  Walter Heindel,et al.  Enhanced neural responsiveness to reward associated with obesity in the absence of food‐related stimuli , 2015, Human brain mapping.

[38]  V. Risbrough,et al.  Pavlovian conditioning to hedonic food cues in overweight and lean individuals , 2015, Appetite.

[39]  Dimitrios Kapogiannis,et al.  Does the brain shrink as the waist expands? , 2015, Ageing Research Reviews.

[40]  M. Alda,et al.  Insulin resistance and outcome in bipolar disorder. , 2015, The British journal of psychiatry : the journal of mental science.

[41]  Tae Hyon Ha,et al.  Body Mass Index–Related Regional Gray and White Matter Volume Reductions in First-Episode Mania Patients , 2014, Biological Psychiatry.

[42]  M. Alda,et al.  Insulin Resistance, Diabetes Mellitus, and Brain Structure in Bipolar Disorders , 2014, Neuropsychopharmacology.

[43]  N. Andreasen,et al.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies , 2013, Neuroscience & Biobehavioral Reviews.

[44]  Anvi Vora,et al.  Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. , 2013, The American journal of psychiatry.

[45]  D. Vancampfort,et al.  Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis. , 2013, Schizophrenia bulletin.

[46]  M. Alda,et al.  Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. , 2012, Journal of psychiatry & neuroscience : JPN.

[47]  M. Alda,et al.  Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment , 2012, Bipolar disorders.

[48]  W. Honer,et al.  The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania , 2011, Biological Psychiatry.

[49]  C. Jack,et al.  Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease. , 2011, Archives of general psychiatry.

[50]  M. Mishkin,et al.  Long-term effects of neonatal medial temporal ablations on socioemotional behavior in monkeys (Macaca mulatta). , 2010, Behavioral neuroscience.

[51]  R. McIntyre,et al.  Bipolar disorder and metabolic syndrome: an international perspective. , 2010, Journal of affective disorders.

[52]  A. Hayes Beyond Baron and Kenny: Statistical Mediation Analysis in the New Millennium , 2009 .

[53]  M. Alda,et al.  Can body mass index help predict outcome in patients with bipolar disorder? , 2009, Bipolar disorders.

[54]  E. Bora,et al.  Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. , 2009, Journal of affective disorders.

[55]  M. Alda,et al.  Rapid cycling bipolar disorders in primary and tertiary care treated patients. , 2008, Bipolar disorders.

[56]  C. Block,et al.  Mechanisms linking obesity with cardiovascular disease , 2006, Nature.

[57]  A. Malla,et al.  Is olanzapine a brain-sparing medication? , 2006, Archives of general psychiatry.

[58]  M. Alda,et al.  Clinical correlates of current level of functioning in primary care-treated bipolar patients. , 2005, Bipolar disorders.

[59]  W. Löscher,et al.  Excessive weight gain in rats over extended kindling of the basolateral amygdala , 2003, Neuroreport.